Apellis Pharmaceuticals (APLS) PT Raised to $20 at Mizuho

March 13, 2026 6:36 AM

Mizuho analyst Graig Suvannavejh raised the price target on Apellis Pharmaceuticals (NASDAQ: APLS) to $20.00 (from $19.00) while maintaining a Neutral rating.

No results found